Compare ARK Genomic Revolution ETF (ARKG) vs Wayfair Inc (W) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Wayfair Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.8, while Wayfair Inc trades at $85.74 (market cap $11.78B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Wayfair Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | W | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $119.05 |
52-Week Low | $23.09 | $53.37 |
Market Cap | — | $11.78B |
Enterprise Value | — | $14.35B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Wayfair (W) trades at $89.23, down 1.18% on the day, with a bullish technical outlook supported by moving averages and a consensus price target of $92.64. The company shows revenue growth to $12.46 billion in 2025 but remains unprofitable with a net loss of $313 million. Recent earnings beat expectations in Q3 and Q4 2025, while Q1 2026 matched estimates. Wayfair is expanding into brick-and-mortar stores and leveraging AI, as highlighted in recent Bloomberg coverage.
The stock presents a mixed outlook: analyst sentiment is positive with 52% buy ratings, but profitability challenges and high debt-to-asset ratio of 95% pose risks. Near-term catalysts include Q2 2026 earnings on August 4, 2026, and store expansion initiatives. Investors should weigh growth potential against persistent losses and competitive pressures in the retail sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Wayfair Inc
Wayfair is a global leader in home goods, operating a massive digital marketplace that connects millions of consumers with thousands of suppliers. It utilizes an asset-light, inventory-light model combined with a proprietary logistics network (CastleGate) and an accelerating brick-and-mortar presence to deliver an end-to-end shopping experience for everything from decor to full home renovations.
Read more on W →
